Note 7 - Stockholders' Deficit

12 Months Ended

Dec. 31, 2015

Stockholders' Equity Note [Abstract]

Note 7 - Stockholders' Deficit

Note 7 – Stockholders’ Deficit

Common Share Issuance - The Company acquired 100% of the membership interests of Newco4pharmacy, LLC. The consideration paid was the issuance of a newly created Series X Preferred stock which was exchanged on December 31, 2015 for 10,000,000 shares of our common stock. The Company obtained approximately $106,900 in cash from Newco4pharmacy. As a result of this transaction, the Company issued shares of 3,488,900 to the CEO and Founder, Stephen Keaveney and 5,797,100 to various individuals and entities that were instrumental in the formation of the N4P business.

Spin-out Transaction – On December 31, 2015 the Company completed the restructuring and spin-out of software educational business. As a result the Company as of December 31, 2015 has 11,765,000 shares outstanding, with 10,000,000 held by the former members of N4P, and 1,765,000 held by the legacy shareholders of the Company and the former educational business, including those who converted their debts into equity. Further, all the shareholders of record date as of December 18, 2015, received shares in the newly formed entity, Trunity, Inc., a Florida corporation, pro-rated to their ownership percentage as of that date. As a result of the restructuring and spin-out, the Company recorded an entry to adjust the capital stock resulting from the spin-out of all the assets and certain liabilities related to the continuing operations of, Trunity, Inc. the educational software business.